GNS CEO Colin Hill joins rank of Top 50 Healthcare Technology CEOs of 2019

by GNS Healthcare | Apr 24, 2019 | Featured Posts, News

The Healthcare Technology Report evaluates the hundreds of CEOs that lead exemplary organizations in the fields of medical devices, biotech, healthcare analytics, healthcare software and other related areas. They gather data on each nominee’s professional background...

Adding Artificial Intelligence to Drug Discovery – Iya Khalil interviewed by GEN News

by GNS Healthcare | Apr 1, 2019 | News

“AI is being used to really leverage learning from large-scale datasets, and those large-scale datasets are used to get to better novel targets.” – Iya Khalil, GNS Co-Founder and COO, joins Mike May of Genetic Engineering & Biotechnology News to...

GNS Co-founder, Iya Khalil interviewed by BioCentury: A Frequentist and a Bayesian Walk Into a Trial

by GNS Healthcare | Mar 26, 2019 | News

GNS Co-Founder and COO Iya Khalil weighed in on the stand-off between Bayesians and frequentist. Read the full piece here.

How A.I. Is Finding New Cures in Old Drugs

by GNS Healthcare | Mar 19, 2019 | Featured Posts, News

GNS CEO and Co-Founder Colin Hill is shares his thoughts on the stat of AI and biopharma with Fortune reporter Tiernan Ray. Read the full article here.

GNS Co-Founder Iya Khalil Named to Forbes list of “50 Women-Led Startups That Are Crushing Tech”

by GNS Healthcare | Feb 22, 2019 | News

GNS Co-Founder Iya Khalil joins 49 other female entrepreneurs who are pushing the frontiers of innovation across various industries. Read the full list here.

GNS Co-Founder and CEO Colin Hill Discusses how AI will Power the Future of in silico Clinical Trials

by GNS Healthcare | Jan 2, 2019 | News

GNS Co-Founder and CEO Colin Hill sat down with Outsourcing Pharma’s Melissa Fassbender to discuss how in silico are making personalized medicine a reality. The interview covered how technology is driving pharma efforts to transition from resource-intensive...